Cumberland Pharmaceuticals Inc (CPIX)

Jul 15, 2025

Why Cumberland Pharmaceuticals Inc. stock attracts strong analyst attentionROI Driven Alerts - Newser

Jul 15, 2025

Jul 15, 2025

How Cumberland Pharmaceuticals Inc. stock performs during market volatilityBest Stocks for Capital Safety - Newser

Jul 15, 2025

Jul 15, 2025

What makes Cumberland Pharmaceuticals Inc. stock price move sharplyChart Breakout Alert - Newser

Jul 15, 2025

Jul 12, 2025

Caroline Young of Cumberland Pharmaceuticals buys CPIX shares By Investing.com - Investing.com Nigeria

Jul 12, 2025

Jul 12, 2025

Caroline Young of Cumberland Pharmaceuticals buys CPIX shares - Investing.com Australia

Jul 12, 2025

Jul 11, 2025

Cumberland Pharma CEO A J Kazimi buys shares worth $807 - Investing.com Australia

Jul 11, 2025

Jul 11, 2025

Cumberland Pharma CEO A J Kazimi buys shares worth $807 By Investing.com - Investing.com Canada

Jul 11, 2025

Jul 11, 2025

Cumberland Pharmaceuticals Advances Ifetroban Study for SSc and SSc-PAH - The Globe and Mail

Jul 11, 2025

Jun 30, 2025

Cumberland Pharmaceuticals Inc.(NasdaqGS:CPIX) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025

Jun 23, 2025

Cumberland reports positive DMD heart drug trial results - Investing.com India

Jun 23, 2025

Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States - openPR.com

Jun 17, 2025

Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech - Barchart.com

Jun 17, 2025

Jun 14, 2025

Two Sigma Investments LP Has $89,000 Stake in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World

Jun 14, 2025

Jun 12, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above Two Hundred Day Moving Average – Here’s Why - Defense World

Jun 12, 2025

Jun 06, 2025

Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock By Investing.com - Investing.com South Africa

Jun 06, 2025

Jun 06, 2025

Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock - Investing.com

Jun 06, 2025

Jun 05, 2025

Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight - GlobeNewswire Inc.

Jun 05, 2025

Jun 04, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World

Jun 04, 2025

Jun 02, 2025

Investors in Cumberland Pharmaceuticals (NASDAQ:CPIX) have seen splendid returns of 235% over the past year - Yahoo

Jun 02, 2025

May 27, 2025

NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS - PR Newswire

May 27, 2025

May 27, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

May 27, 2025

May 22, 2025

Q&A: Cumberland Pharmaceuticals CEO A.J. Kazimi weighs in on industry challenges, strengths - The Business Journals

May 22, 2025

May 21, 2025

Cumberland CEO A.J. Kazimi: Pharmaceutical tariffs would be 'concerning' - The Business Journals

May 21, 2025

May 17, 2025

Dimensional Fund Advisors LP Cuts Stock Position in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World

May 17, 2025

May 14, 2025

Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025 - The Victoria Advocate

May 14, 2025

May 13, 2025

Cumberland, Qureight Collaborate on Lung Disease Treatment Trial - marketscreener.com

May 13, 2025

May 13, 2025

CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH - PR Newswire

May 13, 2025

May 13, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 13, 2025

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Held Back By Insufficient Growth Even After Shares Climb 30% - simplywall.st

May 13, 2025

May 12, 2025

Cumberland Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks

May 12, 2025

May 10, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World

May 10, 2025

May 07, 2025

Cumberland Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks

May 07, 2025

May 07, 2025

Cumberland Pharmaceuticals Inc (CPIX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada

May 07, 2025

May 06, 2025

Cumberland: Q1 Earnings Snapshot - MySA

May 06, 2025

May 06, 2025

Cumberland Pharmaceuticals Inc Reports Q1 2025 Earnings: EPS at $0.16, Revenue Hits $11.7 Million - GuruFocus

May 06, 2025

May 06, 2025

Earnings call transcript: Cumberland Pharmaceuticals sees Q1 2025 revenue jump 38% - Investing.com

May 06, 2025

May 02, 2025

Cumberland Pharmaceuticals Inc.Common Stock (NQ: CPIX - FinancialContent

May 02, 2025

Apr 30, 2025

Renaissance Technologies LLC Sells 21,000 Shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World

Apr 30, 2025

Apr 29, 2025

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE - marketscreener.com

Apr 29, 2025

Apr 28, 2025

Cumberland Pharmaceuticals Shareholders Approve Key Proposals By Investing.com - Investing.com India

Apr 28, 2025

Apr 28, 2025

Cumberland Pharmaceuticals Shareholders Approve Key Proposals - Investing.com

Apr 28, 2025